SPRY4-IT1 was significantly expressed at higher levels in cancer tissues, such as BC, than normal tissues (p < 0.05) and its higher expression also correlated with higher rates of lymph node metastasis (p = 0.002) and recurrence (p = 0.017). Here, SPRY4 is linked to breast cancer.